Multidrug-resistant Escherichia coli in Asia: epidemiology and management

HE Sidjabat, DL Paterson - Expert review of anti-infective therapy, 2015 - Taylor & Francis
Escherichia coli has become multiresistant by way of production of a variety of β-lactamases.
The prevalence of CTX-M–producing E. coli has reached 60–79% in certain parts of Asia …

Antibiotic resistance in wastewater: Occurrence and fate of Enterobacteriaceae producers of Class A and Class C β-lactamases

PP Amador, RM Fernandes, MC Prudêncio… - … Science and Health …, 2015 - Taylor & Francis
Antibiotics have been intensively used over the last decades in human and animal therapy
and livestock, resulting in serious environmental and public health problems, namely due to …

The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

R Azargun, MR Sadeghi, M Hossein… - Infection and drug …, 2018 - Taylor & Francis
Introduction: β-lactam and fluoroquinolone antibiotics are usually used for the treatment of
urinary tract infections (UTIs). The aim of this study was to determine the prevalence of …

Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan

S Abrar, S Hussain, RA Khan, N Ul Ain… - … Resistance & Infection …, 2018 - Springer
Abstract Background South-Asia is known as a hub for multidrug-resistant (MDR) bacteria.
Unfortunately, proper surveillance and documentation of MDR pathogens is lacking in …

[HTML][HTML] Dissemination of extended-spectrum β-lactamases and quinolone resistance genes among clinical isolates of uropathogenic Escherichia coli in children

I Sedighi, MR Arabestani, A Rahimbakhsh… - Jundishapur journal …, 2015 - ncbi.nlm.nih.gov
Background: Urinary tract infection (UTI) is one of the most common childhood bacterial
infections and Escherichia coli is the major pathogen. Producing β-lactamase enzymes are …

[PDF][PDF] Screening of ESBL producing multidrug resistant E. coli from urinary tract infection suspected cases in southern Terai of Nepal

K Yadav, S Prakash - J Infect Dis Diagn, 2017 - academia.edu
Background and objectives: Multidrug-resistant E. coli expressing extended-spectrum β-
lactamase pose serious challenges to clinicians for the therapeutic management of clinical …

[HTML][HTML] Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan

MA Habeeb, Y Sarwar, A Ali, M Salman… - Pakistan journal of …, 2013 - ncbi.nlm.nih.gov
Objectives: Production of extended spectrum beta-lactamases (ESBLs) by clinical isolates of
pathogenic E. coli is a very serious therapeutic threat. This study was aimed to investigate …

[HTML][HTML] Prevalence of extended-spectrum β-lactamases-producing Escherichia coli from Hospitals in Khartoum State, Sudan

ME Ibrahim, NE Bilal, MA Magzoub… - Oman medical …, 2013 - ncbi.nlm.nih.gov
Objective This study aimed to determine the prevalence and assess antimicrobial
susceptibility of extended-spectrum β-lactamase-producing Escherichia coli isolated from …

[PDF][PDF] Prevalence of CTX-M, TEM and SHV beta-lactamases in clinical isolates of Escherichia Coli and Klebsiella Pneumoniae isolated from Aleppo University …

ALS Ibrahim, N Youssef - Archives of Clinical Infectious Diseases, 2015 - brieflands.com
Background: Extended spectrum β-lactamases (ESBLs) have emerged as a major threat
worldwide, with limited treatment options available. Objectives: The present study aimed to …

Fecal carriage of extended-spectrum β-lactamase-and AmpC-producing Escherichia coli among healthcare workers

RH Bassyouni, SN Gaber, AA Wegdan - The Journal of Infection in …, 2015 - jidc.org
Introduction: Commensal E. coli can be considered a reservoir of genes coding for antibiotic
resistance that may be transmitted in hospitals by healthcare workers (HCWs). This study …